🟢 Cerenome is trading 6% up after agreement adds 27.3 million covered lives

Cerenome is trading at $3.92, up 5.95%, on August 13, 2026, after announcing an in-network agreement with Health Care Service Corporation.

• The agreement covers approximately 27.3 million additional commercial and Medicare Advantage lives.
• CNSide’s contracted access rises to approximately 153 million covered lives.
• The expansion is a company-specific catalyst, while broader markets are also modestly higher.